Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
2019 · Human Vaccines & Immunotherapeutics · 97 citations
https://doi.org/10.1080/21645515.2019.1649532
A
Anahita Fathi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
1.1K
Citations
17
h-index
21
i10-index
Anahita Fathi is an academic researcher from Universität Hamburg. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Animal Virus Infections Studies & COVID-19 Clinical Research Studies. The author has an h-index of 17, co-authored 43 publications.
ORCID: 0000-0002-9351-9471Papers by this author
worksScent dog identification of SARS-CoV-2 infections in different body fluids
2021 · BMC Infectious Diseases · 36 citations
https://doi.org/10.1186/s12879-021-06411-1
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
2022 · Cell Reports Medicine · 27 citations
https://doi.org/10.1016/j.xcrm.2022.100685
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
2022 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-022-31557-0
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
2023 · Communications Medicine · 17 citations
https://doi.org/10.1038/s43856-023-00283-z
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
2024 · The Lancet Infectious Diseases · 16 citations
https://doi.org/10.1016/s1473-3099(24)00423-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat